목차
Key Takeaways 1
Introduction 4
The Bayh-Dole Act’s Foundational Role in America’s Tech Economy 4
Universities’ Roles in Regional and National Life Sciences Leadership 8
U S State Competitiveness in Pharmaceuticals and Biotechnology Manufacturing 9
Pharmaceutical and Medicine Manufacturing 9
Biotechnology R&D 11
State-Level Analysis 13
Colorado 14
Colorado’s Tech Economy 14
Universities Anchoring Colorado’s Tech Economy 14
Innovation Vignette: CSU Enables Groundbreaking Genomic Variation Research 16
Innovation Vignette: CSU Advancing Personalized Cancer Treatment 17
Delaware 17
Delaware’s Tech Economy 17
Universities Anchoring Delaware’s Tech Economy 18
Innovation Vignette: University of Delaware Expanding Access to Safe Drinking Water 19
Innovation Vignette: University of Delaware Pioneers Reusable Carbon Fuel 19
Georgia 20
Georgia’s Tech Economy 20
Universities Driving Georgia’s Tech Economy 21
Innovation Vignette: Emory University Pioneers Innovative Cancer Treatment 23
Innovation Vignette: University of Georgia Researcher Treats Dry Eyes 23
Innovation Vignette: University of Georgia Revolutionizes Protein Expression to Treat
Rare Diseases 23
Innovation Vignette: Georgia Tech’s Innovative Solar Cell Manufacturer 24
Indiana 24
Indiana’s Tech Economy 24
Universities Driving Indiana’s Tech Economy 25
Innovation Vignette: Indiana University Research Leads to Rare Disease Cancer Breakthrough 27
Innovation Vignette: Purdue Revitalizes America’s Rare Earth Capabilities 28
Kansas 28
Kansas’s Tech Economy 28
Universities Driving Kansas’s Tech Economy 29
Innovation Vignette: University of Kansas Leading Research Into Drug Metabolism 31
North Carolina 31
North Carolina’s Tech Economy 31
Universities Driving North Carolina’s Tech Economy 32
Innovation Vignette: North Carolina University Develops Innovative Wound Therapies 34
Innovation Vignette: UNC Charlotte Research Enhances Access to Safe Drinking Water 34
Best University Practices Stimulating Technology Commercialization 35
Policy Recommendations 36
Federal Policy Recommendations 36
Increase Federal Investments in University Research 36
Recognize the Direct Link Between Federal R&D Funding and Innovation 40
Make Up for Indirect Cost Cuts With Increased NIH Funding 41
Protect the Bayh-Dole Act 42
Refrain From Introducing Drug Price Controls 44
Reauthorize and Revitalize the SBIR Program 45
Implement a Collaborative R&D Tax Credit 45
Increase R&D Tax Credit Generosity and Restore First-Year Expensing 46
Commit to Regional Technology Hub Investments 46
Advance Promotion and Tenure—Innovation and Entrepreneurship Initiatives 46
State Policy Recommendations 47
Provide Matching SBIR Funding 47
Introduce Collaborative R&D Tax Credits 47
Introduce Innovation Vouchers 47
Leverage “Fund of Funds” Approaches 47
Conclusion 48
Endnotes 49
